Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Treace Medical Concepts (TMCI) Interest & Investment Income (2020 - 2025)

Treace Medical Concepts (TMCI) has disclosed Interest & Investment Income for 6 consecutive years, with $527000.0 as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Interest & Investment Income fell 41.38% year-over-year to $527000.0, compared with a TTM value of $2.8 million through Dec 2025, down 43.06%, and an annual FY2025 reading of $2.8 million, down 43.06% over the prior year.
  • Interest & Investment Income was $527000.0 for Q4 2025 at Treace Medical Concepts, down from $634000.0 in the prior quarter.
  • Across five years, Interest & Investment Income topped out at $2.0 million in Q2 2023 and bottomed at -$1000.0 in Q1 2021.
  • Average Interest & Investment Income over 5 years is $787700.0, with a median of $787000.0 recorded in 2022.
  • The sharpest move saw Interest & Investment Income tumbled 103.03% in 2021, then soared 16333.33% in 2023.
  • Year by year, Interest & Investment Income stood at $5000.0 in 2021, then skyrocketed by 15880.0% to $799000.0 in 2022, then soared by 113.89% to $1.7 million in 2023, then crashed by 47.4% to $899000.0 in 2024, then plummeted by 41.38% to $527000.0 in 2025.
  • Business Quant data shows Interest & Investment Income for TMCI at $527000.0 in Q4 2025, $634000.0 in Q3 2025, and $775000.0 in Q2 2025.